Sundial and Delta 9 Cannabis Sign Supply Agreement for up to Five Million Grams of Product
15 3월 2018 - 5:30PM
Sundial Growers Inc. (“Sundial”) announced today that the company
has entered into a Memorandum of Understanding (“MOU”) to supply up
to five (5) million grams of cannabis and cannabis derivative
products per year to Delta 9 Cannabis Inc. (“Delta 9”).
“This supply agreement enables Sundial to expand into the
Manitoba market. We are thrilled to be able to provide Manitoba
residents with quality cannabis products through Delta 9,” said
Sundial’s Chief Commercial Officer, Andrew Stordeur. “Sundial
applauds Delta 9 for building a strong partnership framework to
ensure that Manitoba has a sufficient supply of cannabis.”
Both parties have agreed to share market data and marketing
strategies in order to ensure that the production and delivery of
product is optimized to meet consumer preferences and demand. The
parties will also work together on product trials, marketing and
branding strategies, technology services and education.
“Delta 9 is committed to working with Sundial to ensure that we
meet or exceed our supply projections in order to satisfy the needs
of Manitobans,” said CEO John Artbuthnot, from Delta 9. “No one can
definitively predict what will happen in the cannabis market in the
first year after legalization, but early indicators suggest that
demand will increase dramatically, and Delta 9 intends to be ready
for that demand.”
All clauses in the MOU are pending provincial regulatory
structures and Health Canada approvals and regulations. Product
supplied by Sundial will be subject to the terms and policies of
the provincial regulatory authority within the jurisdiction of the
supply agreement. Sundial is required to supply cannabis that meets
or exceeds Health Canada standards and has agreed to warrantee such
quality to Delta 9 and its customers.
About Sundial Growers Inc. Sundial Growers Inc.
(“Sundial”) is a privately held, Alberta-based Health Canada
ACMPR-approved licensed producer of medical cannabis. Sundial
combines tried and true heartland farming practices with innovative
horticultural techniques to grow a select range of cannabis
strains. Our focus is on producing consistent cannabis that our
customers can trust.
Sundial currently operates an 31,000 square foot production
facility in Rocky View, Alberta, and has two separate production
facilities in various stages of completion and licensing. By 2020,
we expect to be one of the leading cannabis companies in the
country with a projected production of over 100 million grams of
dry cannabis and over 32 million grams of concentrate or cannabis
extract.
For more information about Sundial Growers Inc., visit
www.sundialgrowers.com.
About Delta 9 Cannabis Inc. Delta 9’s
wholly-owned subsidiary, Delta 9 Bio-Tech Inc., is a licensed
producer of medical marijuana pursuant to the ACMPR and operates an
80,000 square foot production facility in Winnipeg, Manitoba,
Canada. Delta 9’s shares trade on the TSX Venture Exchange under
the symbol “NINE”.
Media Contact:Claire Buffone-Blair, Director of Communications
& Stakeholder RelationsSundial Growers Inc. C: 1.403.471.6378E:
claire@sundialgrowers.com
Gary Symons, Director of CommunicationsDelta 9 Cannabis Inc.C:
250.300.9352E: communications@delta9.ca
Delta 9 Cannabis (TSXV:NINE)
과거 데이터 주식 차트
부터 10월(10) 2024 으로 11월(11) 2024
Delta 9 Cannabis (TSXV:NINE)
과거 데이터 주식 차트
부터 11월(11) 2023 으로 11월(11) 2024